Discover real-time Bionano Genomics, Inc., BNGO stock Forecast prices for 2025, 2030, 2035, 2040, 2045, 2050, and 2060, quotes, historical data, BNGO stock predictions, and expert insights.
Key Takeaways: for BioNano Genomics (BNGO) in the last 3 months:
- The average price target is $5.13 with a high forecast of $6.98 and a low forecast of $2.05. The average price target represents a 362.50% change from the last price of $1.07.
- BNGO’s revenue is expected to rise from $38.50 million this year to $48.70 million next year, while its (Earnings Per Share) EPS is projected to improve from -$1.70 to -$1.10.
Table of Contents
Read: VERI Stock Forecast 2025, 2030, 2040 Veritone Analyst Estimate, Price Target
What is Bionano Genomics, Inc.?
BioNano Genomics, Inc. (NASDAQ: BNGO) is dedicated to enhancing health and wellness for all individuals through customer-centered innovations that revolutionize genomic understanding. The company is committed to elevating shareholder value through outstanding business performance and practices.
Specializations and Services
BioNano specializes in optical genome mapping (OGM) solutions, providing a range of services, software, and tools designed for genome mapping and analysis. Their offerings include Dx services, which are diagnostic services used to detect and interpret various genetic conditions, alongside advanced genome analysis software that enables genomics laboratories to analyze and interpret data across diverse platforms.
By transforming the way the world views and understands the genome, BioNano Genomics aims to bring cutting-edge genomic analysis capabilities to the forefront of healthcare, fostering advancements in medical research, diagnostics, and personalized medicine.
Company Profile
| Compnay | Bionano Genomics, Inc. |
|---|---|
| Exchange | NASDAQ-CM |
| Sector | Industrial – Healthcare |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| CEO | Dr. Robert Erik Holmlin |
| Employees | 344 |
| Website | www.bionano.com |
Read: VRTX Stock Forecast 2025,2030,2040 Vertex Pharmaceuticals Price Prediction
Bionano Genomics, Inc. Financial Summary (BNGO: NASDAQ)
Bionano Genomics, Inc. (BNGO: NASDAQ)has demonstrated notable progress in its financial health for the first quarter of 2024. The company has achieved a healthy revenue growth of 18.2% and managed to reduce its net loss by 15.3% compared to the same period last year. The reduction in both basic and diluted loss per share from USD 1.23 to USD 0.6 further underscores the company’s improvements in financial management. While challenges remain, the overall financial trajectory indicates a positive outlook for Bionano Genomics.
| Financial Metric | Q1 2024 | Q1 2023 | YOY |
|---|---|---|---|
| Revenue | USD 8.77 million | USD 7.42 million | 18.2% increase |
| Net Loss | USD 31.42 million | USD 37.12 million | 15.3% improvement |
| Basic Loss per Share | USD 0.6 | USD 1.23 | N/A |
| Diluted Loss per Share | USD 0.6 | USD 1.23 | N/A |
Related News: STRO Stock Forecast 2025, 2030, 2040 Price Target and Prediction
Bionano Genomics, Inc. (BNGO) Fundamental Analysis
| Previous Close | $1.0300 |
| Open | $1.0600 |
| Day’s Range | $1.0400 – $1.0900 |
| 52 Week Range | $0.7100 – $8.2000 |
| Share Volume | 646,474 |
| Average Volume | 1,418,168 |
| Market Cap (intraday) | 71.537M |
| Beta (5Y Monthly) | 2.41 |
| P/E Ratio (TTM) | |
| Forward P/E 1 Yr. | -0.55 |
| Earnings Per Share (EPS) | $-6.1800 |
| Earnings Date | Aug 7, 2024 – Aug 12, 2024 |
Bionano Genomics, Inc. (BNGO) Historical Chart by Trading View
Long-term BNGO price forecast for 2025, 2030, 2035, 2040, 2045, 2050, and 2060
According to our current BNGO stock forecast, the value of BioNano Genomics shares will reach $4.90 by last of 2024, then the BNGO Share price will hit $6.80 by March 25, 2025, BioNano Genomics stock prediction for 1 year compared to the previous year’s will rise $ 17.50 in 2029, BNGO stocks could skyrocket to $24.50 by end of 2030, $41 in 2040, $85, in 2050, and $106.00 by 2060.
| Year | Prediction | Change |
|---|---|---|
| 2024 | $4.93 | 10.15% |
| 2025 | $6.80 | 536.45% |
| 2029 | $17.50 | 1531.78% |
| 2030 | $24.50 | 2196.26% |
| 2035 | $31.00 | 2799.07% |
| 2040 | $41.00 | 3738.32% |
| 2045 | $55.00 | 5037.38% |
| 2050 | $85.00 | 7887.85% |
| 2060 | $106.00 | 9822.43% |
More to Go: UNH STOCK FORECAST 2025, 2030, 2040: Is UNH a buy or a sell?
BNGO Stock Forecast 2024
Based on the current BNGO stock forecast, it’s projected that the value of BioNano Genomics shares will experience a decrease of -22.20%, reaching $0.83245 per share by May 30, 2024. The technical indicators suggest a bearish sentiment from its current price.
BNGO Stock Forecast 2025
Price Targets for Bionano Genomics, Inc. (BNGO) stock will peak at a stock price of $6.80 by May 28, 2025, quarterly revenue of $31 million by December 31, 2025, and quarterly earnings per share of -$0.09 by December 31, 2025. This is a whopping 536.45% upside potential from its current price.
BNGO Stock Forecast 2030
BioNano Genomics Inc. (BNGO) stock forecast is expected to reach an average price target of $24.50 in 2030. BNGO stock annual earnings is 0.93 per share representing a 2196.26% rise from the current price.
BNGO Stock Forecast 2040
BioNano Genomics Inc. (BNGO) stock is expected to hit a record-high average price target of around $38.00 per share by 2040 with a high prediction of $41 and a low estimate of $21.81. The average price target represents an increase of 378.64% from the last closing price.
BNGO Stock Forecast 2050
Looking at Bionano Genomics Inc. financial reports and earnings the shares of BNGO will skyrocket to an average target of $51.00 per share by 2050 with a high prediction of $55.00 and a low estimate of $41.81 reaching a 7887.85% upside potential. This prediction is based on the 10-year average growth rate of BNGO shares from its current price.
BNGO Stock Forecast 2060
Based on the latest analysis, Bionano Genomics (BNGO) stock forecast for 2060 will experience a Whopping increase of 9822.43% per share with a high prediction of $106.00, a median target of $100 and a low estimate of $91.81 from its current price.
Other sources: BNTX Stock Forecast 2025, 2030, 2040 BioNTech SE Price Prediction
Conclusion: Is BioNano Genomics (BNGO) a wise investment?
BioNano Genomics shows promising long-term growth potential. Despite short-term bearish forecasts and the potential risks associated with the reverse stock split, the overall outlook for BNGO suggests it could be a good investment for those willing to navigate the short-term volatility and focus on long-term gains. Recent financial improvements, such as a notable revenue increase and a reduction in net loss, indicate positive financial health.
What is the BNGO prediction for 2025?
The BNGO stock prediction for 2025 from today is $6.80, assuming that this prediction is based on the 10-year average growth rate of BNGO a -0.39% increase in the BNGO stock price.
What will BNGO’s net worth look like in 2040?
Assuming that BNGO grows at an 11.13% CAGR of the S&P 500, the stock could reach $41 by 2040, which would be a 3738.32% increase compared to today’s rates.
What is the price prediction for BioNano Genomics in 2030?
The BNGO price prediction for 2030 is between $38 on the lower end and $ 41 on the high end.
Is there a reverse split for BNGO?
Bionano Genomics, Inc. (BNGO) has announced a one-for-ten (1-10) reverse split of its Common Stock, which may result in investors experiencing losses due to potential fluctuations in trading prices following reverse stock splits.
Ashish Dwivedi is the founder and chief editor of MoneyMystica, a top resource for finance, insurance, and share market insights. Driven by a passion for empowering individuals to make informed financial decisions, Ashish uses his extensive knowledge and practical experience to offer clear and actionable advice.
